![]() |
|
|||
|
London Indianapolis-based Eli Lilly & Co.'s Alimta has won the preliminary backing of a U.K. agency as a maintenance treatment for patients with the most common form of lung cancer.
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Breast cancer drug did not extend lives: U.S. agency | cancerfr | Breast Cancer | 0 | 07-17-2010 09:40 AM |
| Partial response seen with Lilly melanoma drug | cancerfr | Melanoma | 0 | 05-23-2010 02:52 AM |
| UPDATE 1-Partial response seen with Lilly melanoma drug | cancerfr | Melanoma | 0 | 05-23-2010 02:52 AM |
| Study: Lilly osteoporosis drug cuts chance of cancer | cancerfr | Vaginal Cancer | 0 | 04-21-2010 09:55 PM |
| Study: Lilly drug cuts cancer risk | cancerfr | Endometrial Cancer | 0 | 04-20-2010 11:15 PM |